LLY vs GILD Comparison
Compare financials and metrics between Eli Lilly and Company (LLY) and Gilead Sciences, Inc. (GILD)
Stock Comparison
| Metric | LLY | GILD |
|---|---|---|
| Market Cap | $838.5 B | $128.6 B |
| Gross Margin | 82% | 1% |
| Profit Margin | 33% | 24% |
| EBITDA margin | 45% | 32% |
| Quarterly Revenue | $13.5 B | $7.6 B |
| Quarterly Earnings | $4.4 B | $1.8 B |
| Quarterly Free Cash Flow | $0 B | $3.0 B |
| Trailing 4 Quarters Revenue | $45.0 B | $28.8 B |
| Trailing 4 Quarters Earnings | $10.6 B | $480.0 M |
| Quarterly Earnings Growth | 101% | 25% |
| Annual Earnings Growth | 425% | -94% |
| Quarterly Revenue Growth | 45% | 6% |
| Annual Revenue Growth | 19% | 2% |
| Cash On Hand | $0 | $0 |
| Short Term Debt | $0 | $0 |
| Long Term Debt | $0 | $0 |
| PE | 79.18 | 267.95 |
| PS | 18.62 | 4.47 |
| PB | 58.55 | 2.18 |
| PC | -1.00 | -1.00 |
| Liabilities to Equity | -1.00 | 0.00 |
| ROA | -100% | 1% |
| ROE | 74% | -100% |
| Current Ratio | 0.00 | -1.00 |
| Quick Ratio | -0.25 | -1.00 |
| Long Term Debt to Equity | 0.00 | -1.00 |
| Debt to Equity | 0.00 | -1.00 |
| Burn Rate | 0.00 | 0.00 |
| Cash to Cap | 0.00 | 0.00 |
| CCR | 0.00 | 1.67 |
| EV to EBITDA | 136.37 | 52.47 |
| EV to Revenue | 18.62 | 4.47 |